Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- 最新申報
- 2024/11/14
2024 年第 2 季持倉
持倉截至 2024/6/30，2024/8/14 申報。只含多頭部位，變化是跟 2024 年第 1 季比股數。
- 持股檔數
- 59
- 較 2024 年第 1 季 −6
- 總值
- $2.87 億
- 較 2024 年第 1 季 −$2,370 萬 (−7.6%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 490,000 | $1,701 萬 | 5.9% | +205,000+71.9% | 加碼 | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 300,000 | $1,319 萬 | 4.6% | 00.0% | 不變 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 300,000 | $1,224 萬 | 4.3% | +100,000+50.0% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 150,000 | $1,208 萬 | 4.2% | −60,000−28.6% | 減碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 86,721 | $1,183 萬 | 4.1% | +86,721 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 150,000 | $1,133 萬 | 3.9% | +55,000+57.9% | 加碼 | 歷史 |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 240,000 | $1,075 萬 | 3.7% | +40,000+20.0% | 加碼 | 歷史 |
| ROIVRoivant Sciences Ltd. | SHS | 1,000,000 | $1,057 萬 | 3.7% | −300,000−23.1% | 減碼 | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 925,000 | $922.2 萬 | 3.2% | +925,000 | 新進 | 歷史 |
| TGTXTG Therapeutics, Inc. | COM | 500,000 | $889.5 萬 | 3.1% | −325,000−39.4% | 減碼 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 55,000 | $869.0 萬 | 3.0% | −70,000−56.0% | 減碼 | 歷史 |
| CGONCG Oncology, Inc. | COM | 260,000 | $820.8 萬 | 2.9% | +185,000+246.7% | 加碼 | 歷史 |
| CRBPCorbus Pharmaceuticals Holdings, Inc. | COM NEW | 175,000 | $791.9 萬 | 2.8% | +118,059+207.3% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 587,708 | $764.6 萬 | 2.7% | −37,292−6.0% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 350,000 | $718.5 萬 | 2.5% | +200,000+133.3% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 260,000 | $686.4 萬 | 2.4% | +135,000+108.0% | 加碼 | 歷史 |
| TARSTarsus Pharmaceuticals, Inc. | COM | 235,000 | $638.7 萬 | 2.2% | −65,000−21.7% | 減碼 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 600,000 | $618.0 萬 | 2.2% | +115,000+23.7% | 加碼 | 歷史 |
| RZLTRezolute, Inc. | COM NEW | 1,421,501 | $611.2 萬 | 2.1% | +1,421,501 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 550,000 | $595.1 萬 | 2.1% | +350,000+175.0% | 加碼 | 歷史 |
| SYRESpyre Therapeutics, Inc. | COM NEW | 250,237 | $588.3 萬 | 2.0% | +150,237+150.2% | 加碼 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 22,500 | $546.8 萬 | 1.9% | −37,500−62.5% | 減碼 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 135,000 | $517.9 萬 | 1.8% | +5,000+3.8% | 加碼 | 歷史 |
| VKTXViking Therapeutics, Inc. | COM | 95,000 | $503.6 萬 | 1.8% | +21,998+30.1% | 加碼 | 歷史 |
| RYTMRhythm Pharmaceuticals, Inc. | COM | 117,388 | $482.0 萬 | 1.7% | −7,612−6.1% | 減碼 | 歷史 |
| INSMINSMED Inc | COM PAR $.01 | 65,000 | $435.5 萬 | 1.5% | −85,000−56.7% | 減碼 | 歷史 |
| BPMCBlueprint Medicines Corp | COM | 40,000 | $431.1 萬 | 1.5% | −32,761−45.0% | 減碼 | 歷史 |
| SVRASavara Inc | COM | 1,050,876 | $423.5 萬 | 1.5% | −549,124−34.3% | 減碼 | 歷史 |
| TNYATenaya Therapeutics, Inc. | COM | 1,350,000 | $418.5 萬 | 1.5% | +575,000+74.2% | 加碼 | 歷史 |
| REPLReplimune Group, Inc. | COM | 450,000 | $405.0 萬 | 1.4% | −200,000−30.8% | 減碼 | 歷史 |
| ENGNenGene Therapeutics Inc. | COM | 420,331 | $396.4 萬 | 1.4% | +220,331+110.2% | 加碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 225,000 | $365.6 萬 | 1.3% | 00.0% | 不變 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 140,000 | $354.6 萬 | 1.2% | −35,000−20.0% | 減碼 | 歷史 |
| KRROKorro Bio, Inc. | COM | 100,000 | $338.7 萬 | 1.2% | +100,000 | 新進 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 1,150,000 | $335.8 萬 | 1.2% | +1,150,000 | 新進 | 歷史 |
| BBOTBridgeBio Oncology Therapeutics, Inc. | CL A ORD SHS | 300,000 | $306.6 萬 | 1.1% | 00.0% | 不變 | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 1,250,000 | $280.0 萬 | 1.0% | +300,000+31.6% | 加碼 | 歷史 |
| CABACabaletta Bio, Inc. | COM | 370,899 | $277.4 萬 | 1.0% | −4,101−1.1% | 減碼 | 歷史 |
| NGNENeurogene Inc. | COM | 70,000 | $254.7 萬 | 0.9% | +45,000+180.0% | 加碼 | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 50,000 | $209.4 萬 | 0.7% | +50,000 | 新進 | 歷史 |
| ARVNArvinas, Inc. | COM | 75,000 | $199.7 萬 | 0.7% | +35,000+87.5% | 加碼 | 歷史 |
| RGNXREGENXBIO Inc. | COM | 170,000 | $198.9 萬 | 0.7% | +50,000+41.7% | 加碼 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 33,200 | $179.9 萬 | 0.6% | +13,200+66.0% | 加碼 | 歷史 |
| ELEVElevation Acquisition Group Inc. | COM | 600,000 | $162.0 萬 | 0.6% | +350,000+140.0% | 加碼 | 歷史 |
| KRYSKrystal Biotech, Inc. | COM | 8,500 | $156.1 萬 | 0.5% | −5,500−39.3% | 減碼 | 歷史 |
| ANNXAnnexon, Inc. | COM | 310,000 | $151.9 萬 | 0.5% | +310,000 | 新進 | 歷史 |
| PRQRProQR Therapeutics N.V. | SHS EURO | 900,000 | $149.4 萬 | 0.5% | +900,000 | 新進 | 歷史 |
| ATYRaTYR PHARMA INC | COM NEW | 800,000 | $124.8 萬 | 0.4% | +200,000+33.3% | 加碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 200,000 | $99.8 萬 | 0.3% | +200,000 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 35,000 | $91.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| SGMTSagimet Biosciences Inc. | COM SER A | 225,000 | $77.0 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 10,000 | $68.5 萬 | 0.2% | +10,000 | 新進 | 歷史 |
| MGNXMacrogenics Inc | COM | 150,000 | $63.8 萬 | 0.2% | +150,000 | 新進 | 歷史 |
| PMVPPMV Pharmaceuticals, Inc. | COM | 375,000 | $60.8 萬 | 0.2% | −300,000−44.4% | 減碼 | 歷史 |
| PTCTPTC Therapeutics, Inc. | COM | 19,000 | $58.1 萬 | 0.2% | +19,000 | 新進 | 歷史 |
| RVNCRevance Therapeutics, Inc. | COM | 225,000 | $57.8 萬 | 0.2% | −225,000−50.0% | 減碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 25,000 | $56.0 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 219,331 | $47.2 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 300,000 | $36.6 萬 | 0.1% | −300,000−50.0% | 減碼 | 歷史 |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2024 年第 1 季之後清倉（18 檔）
2024 年第 1 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2024 年第 1 季股數 | 2024 年第 1 季市值 | 2024 年第 1 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| CATXPerspective Therapeutics, Inc. | COM | 6,000,000 | $714.0 萬 | 2.3% | 歷史 |
| JBIOJade Biosciences, Inc. | COM | 225,000 | $665.3 萬 | 2.1% | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 75,000 | $321.4 萬 | 1.0% | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 450,000 | $302.4 萬 | 1.0% | 歷史 |
| AQSTAquestive Therapeutics, Inc. | COM | 702,941 | $299.5 萬 | 1.0% | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 176,513 | $277.7 萬 | 0.9% | 歷史 |
| GERNGeron Corp | COM | 800,000 | $264.0 萬 | 0.8% | 歷史 |
| MRNSMarinus Pharmaceuticals, Inc. | COM NEW | 285,000 | $257.6 萬 | 0.8% | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 250,000 | $254.5 萬 | 0.8% | 歷史 |
| KALVKalVista Pharmaceuticals, Inc. | COM | 200,000 | $237.2 萬 | 0.8% | 歷史 |
| NTRANatera, Inc. | COM | 25,000 | $228.7 萬 | 0.7% | 歷史 |
| PTGXProtagonist Therapeutics, Inc | COM | 75,000 | $217.0 萬 | 0.7% | 歷史 |
| EYPTEyePoint, Inc. | COM NEW | 90,000 | $186.0 萬 | 0.6% | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 6,500 | $173.6 萬 | 0.6% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 115,000 | $161.9 萬 | 0.5% | 歷史 |
| LRMRLarimar Therapeutics, Inc. | COM | 210,603 | $159.8 萬 | 0.5% | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 20,000 | $93.4 萬 | 0.3% | 歷史 |
| QUREuniQure N.V. | SHS | 165,000 | $85.8 萬 | 0.3% | 歷史 |